Clinical evaluation of the Sarns membrane oxygenator

Abstract

A new membrane oxygenator, developed by Travenol Laboratories, has been introduced by Sarns/3M. The oxygenator is constructed of microporous polypropylene hollow fibres wound into a gas transfer module with an effective surface area of 1.8m2 and a total priming volume of 320ml. This was made possible by using computer-aided design techniques. Blood flow is perpendicular over the fibre in the module while the gas flow is directed within the fibres. The unit contains an integral stainless steel heat exchanger mounted beneath the fibre module. A selection of collapsible venous reservoirs is available to fulfil various patient requirements. The oxygenator and venous reservoir bag are mounted on a wire frame holder that can be arranged in any direction on the heart lung machine. The circuit was primed with 1800ml of a balanced electrolyte solution, 200ml of 25% albumin and 200ml of 25% mannitol, to which 4000 units of beef lung heparin were added. The 1000ml reservoir was used in all cases.

Seventeen consenting adult patients undergoing elective cardiac surgery participated in the clinical evaluation. Haematology and organ function studies indicated no significant changes attributable to the oxygenator. The mean postbypass plasma-free haemoglobin elevation was 8.2mg/dl. The mean postbypass haematocrit and platelet count reduction were 21 % and 27% respectively, indicating that platelet count tended to follow haemodilution with minimal loss. There were no gas exchange nor acid-base problems encountered. The mean PaO₂ and PaCO₂ were 267mmHg and 42mmHg respectively with a maximum O₂ transfer of 241 ml/min during the study.

Get full access to this article

View all access options for this article.

References

Code of Federal Regulations. Food and drug administration. In: Title 21 - Food and Drugs, 1983: Parts 1-99, Parts 800-1299.

Dearing JP , James DA , Sutton RG , Kratz JM , Crawford FC Clinical trials of a new low prime hollow fiber membrane oxygenator . JECT 1986; 18: 49-54.

Sinkewich M. , Ogella D. , Golding LR , Stewart R. , Meserko J. Early clinical experiences with the new Bentley oxygenator system-capillary membrane (BOS-CM) . Proc Amer Acad Cardiovasc Perf 1984; 5: 125-29.

Sinkewich MG , Meserko JJ , Golding LR , Loop FD Clinical evaluation of the Terumo hollow fiber membrane oxygenator. Proc Amer Acad Cardiovasc Perf 1982; 3: 13-16.

Stewart SR , Gaich-Hood PA , Fallen DM , McClosky ME Development of a new hollow fiber membrane oxygenator Part II: clinical evaluation . Proc Amer Acad Cardiovasc Perf 1984; 5: 118-24.

Iatridis A. , Chan T. , Thompson R. Experimental and clinical trials with the extracorporeal hollow fiber lung . Proc Amer Acad Cardiovasc Perf 1985 ; 6: 47-50.

Dearing JP , Crawford FC , Kratz JM , Stroud M. Clinical use of a new membrane oxygenator. JECT 1984; 16: 125-29.

Massimino RJ , Stearns GT , Gough JD , Martin J. , Karlson K. Clinical evaluation of a microporous hollow-fiber membrane oxygenator with a large gas transfer capability. JECT 1984 ; 16: 51-54.

Fox DJ Clinical evaluation and experience with the Cobe membrane lung oxygenator with integral cardiotomy filter. Proc Amer Acad Cardiovasc Perf 1984; 5: 130-34.